Skip to main content

Table 1 Study schedule of enrolment, interventions and assessments

From: Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol

  1. ATEND Adult test of neuromuscular disorders, CMAP Compound muscle action potential, ESTCS Endurance shuttle combined score, HFMSE Hammersmith functional motor scale expanded, RNS Repetitive nerve stimulation, RULM Revised upper limb module, SMN2 Survival motor neuron 2gene, SNAP Sensory nerve action potential, T0 Baseline measurement, T1 Two months after start of treatment, T2 Fourteen or ten months after start of treatment with nusinersen or risdiplam, respectively
  2. aAssessments only for patients treated with nusinersen
  3. bAssessment only for patients treated with risdiplam
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us